Aclaris Therapeutics: Q2 Earnings Insights


Aclaris Therapeutics ACRS reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.


Aclaris Therapeutics beat estimated earnings by 13.89%, reporting an EPS of $-0.31 versus an estimate of $-0.36.

Revenue was down $296 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.09 which was followed by a 8.63% drop in the share price the next day.

Here's a look at Aclaris Therapeutics's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.40 -0.36 -0.28 -0.29
EPS Actual -0.31 -0.37 -0.35 -0.34
Revenue Estimate 1.66M 1.79M 1.77M 1.69M
Revenue Actual 1.45M 1.50M 1.66M 1.82M

To track all earnings releases for Aclaris Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!